Code of LongevityThe Evolution of Luxury: From Million-Dollar Watches to Longevity Biomarkers
Franc Smidt, Editor-in-Chief of FUTURUM
August 14, 2025, Germany
For centuries, wealth has been measured and expressed through objects of luxury. A Rolex on the wrist, a rare supercar in the garage, a villa on Lake Como — all of these have long been symbols of success. But in the 21st century, the main signs of wealth and luxury have begun to change. Today, the elite are buying less and less “things” — they are buying years. And the higher the price of health, the louder the new indicators of status become: biological age, perfect biomarkers, and the complete absence of inflammatory processes.
This striking shift is confirmed by numbers. A twenty-year global meta-analysis revealed that among the wealthiest 20% of the world’s population, virtually all key health indicators have improved over the past two decades: the average duration of active life has increased by almost 6.4 years, the risk of cardiovascular diseases has dropped by 38%, and cognitive functions in older ages show record resilience. Among the remaining 80%, however, the trend is exactly the opposite: type II diabetes is rising, dementia is occurring earlier, and obesity is becoming the new normal. Money now literally buys better blood, cleaner biomarkers, and a younger biological age.
Clinics Straight Out of “Black Mirror”
In Germany and Switzerland, medical centers already exist that resemble futuristic laboratories more than traditional hospitals. Patients undergo a full-body scan: 3D mapping of vessels and organs, DNA sequencing, monitoring of metabolic pathways, and the creation of an interactive “health passport.” The final report looks like a work of art: perfect graphs, risk dynamics, and a personal map of biological age.
The waiting list for such centers can reach 30,000–40,000 people. And the cost of annual service is comparable to that of a new Bentley. The irony of the era is that the owners of these “health passports” post screenshots of their biomarkers on social media with the same pride once reserved for flaunting a golden Daytona or a collection of Patek Philippe.
BIO+ Longevica: Germany’s Answer to the Race for Immortality
In this new health economy, Germany is becoming a magnet for the elite and investors — and therefore for innovators and advanced technologies as well. One of the new players illustrating this paradigm shift and fast-growing trend is the Bavarian biotech startup BIO+ Longevica™. Its team is developing next-generation phytopharmaceuticals designed to act not on symptoms but on the root mechanisms of aging.
The company’s synergistic formulations are based on over 70 isolated functional terpenes, more than 100 alkaloids, and dozens of unique flavonoids, whose effectiveness is supported by studies published in authoritative journals such as Nature Aging and Frontiers in Pharmacology. The startup also integrates innovative ion-exchange enterosorbents that cleanse the body of toxins and inflammation markers, while simultaneously building its own unique digital longevity platform, BioPlus™.
According to the founders, the platform will leverage AI-driven personalization: users anonymously upload their biomarkers, DNA data, and metabolic test results, and the algorithm generates a dynamic longevity roadmap. The German nutraceuticals market is already estimated at €27–34 billion, with the premium active-longevity segment growing at double-digit rates. Startups in this field are therefore well-positioned for success.
When Health Became Currency
The paradox is that access to new life-extension technologies has itself become a marker of class. The elite undergo full check-ups every quarter, monitor dozens of biomarkers in real time, and adjust their nutrition, lifestyle, and therapeutic protocols “on the fly.” Meanwhile, the rest of the population remains stuck in a standardized medical model where prevention is impossible and treatment comes too late.
Economists call this phenomenon “biological divergence”: by 2040, the gap in active life expectancy between the wealthiest and the poorest may exceed 15 years. This means that health is becoming not only a personal luxury but a new form of currency — an asset more valuable than yachts, paintings, and even digital tokens.
The Age of Health Charts Instead of Rolex
Popular glossy magazines are already changing their covers. Instead of photographs of limited-edition watches or yachts, they now feature perfect “health charts” and wearable devices for personal health optimization. On social media, people boast about their telomere dynamics, cognitive resilience index, metabolic aging speed, and even their “ideal” physical state.
For the first time in history, data about your body can be worth more than a collection of vintage wines. This is how values are shifting in the AI era. And while mainstream medicine lags behind by decades, the elite are building their own health ecosystems. Clinics of the future, neural networks for personalized prevention, and next-generation treatments like BIO+ Longevica — all of this is shaping a new social contract: the right to health is becoming the privilege of the wealthy.
It is clear that technologies and innovations still have a long way to go before healthy, active longevity becomes truly accessible to the majority.
